reSee.it - Related Video Feed

Speaker 0 argues that because it’s classified as a vaccine, they don’t have to worry about being sued. Speaker 1 counters that there is immunity from liability dependent on there having been no fraud, and asserts that there clearly was fraud, so in light of that... Speaker 0 expresses surprise at known caveats to liability. Speaker 1 confirms the caveats and says it makes the situation more interesting. Speaker 0 asks how fraud is defined in this context, noting that drugs were sold with many studies but only one was good. Speaker 1 responds, “Let's try this one,” and discusses safety testing: the insufficient amount of safety testing before release was done with mRNA vaccines produced in a process that did not involve DNA. The product injected into billions of people involved DNA plasmids, with massive contamination in the shots actually delivered, including the SV40 promoter (simian virus 40). The point is that safety testing was performed on one process, but people were injected with something different that had other components not tested, which Speaker 1 calls fraudulent. Speaker 0 asks for an explanation of the SV40 issue. Speaker 1 explains production methods: techniques to generate product using a plasmid, a circular piece of DNA, allowing vats to grow the product before coating in lipid nanoparticle, with bacteria doing the work. There is a requirement to purify DNA and set standards for residual DNA contamination. In this case, not only was quality control poor, but there was a much more painstaking way to produce the same product that did not involve DNA plasmids at all. As a result, vials given to Kevin McKernan, containing material actually injected into people, showed DNA contamination across the board. Speaker 1 states that leftover DNA includes the SV40 promoter, a genetic trigger from simian virus 40, which is carcinogenic. This promoter is left over in vials from shots actually injected into people, implying that the claims about the potential for mRNA shots to integrate into the genome were incorrect. Speaker 1 asserts that there is DNA in the vials, not just some old DNA, and that it includes the SV40 promoter, a genetic engineering tool with carcinogenic potential. Therefore, Speaker 1 concludes, this seems to be clear fraud: you can’t inject a different product into the public on the basis of safety testing conducted with a product produced by a different process.

Speaker 0 describes a highly significant and controversial issue surrounding human papillomavirus (HPV) vaccines, including Gardasil and Cervarix, and reports that lawsuits are occurring worldwide. In Japan, there have been major lawsuits with hundreds of plaintiffs, including young women and girls, though the fundamental problem, according to the speaker, centers on contamination with DNA impurities. The speaker states that from the early days of the Ministry of Health, Labour and Welfare in Japan, the core issue has been the contamination with DNA impurities in vaccines, and that this problem had already become clear by 2012 in a widely cited paper. The speaker explains that by 2012, a paper described the DNA contamination in Gardasil-related vaccines, specifically noting residual DNA fragments from HPV types 16 and 18 associated with the vaccine’s aluminum adjuvant particles. The claim is that vaccine samples contained residual HPV DNA fragments that were directly bound to aluminum adjuvant particles, and that PCR tests confirmed these DNA fragments were identical to the HPV sequences described in the paper. The speaker emphasizes that researchers around the world—doctors and researchers listening to women and girls’ voices—noticed unusual, severe post-vaccination symptoms in children and young women, and saw potential links between these symptoms and the residual HPV DNA attached to adjuvants. The testimony references samples gathered from multiple countries (Australia, Bulgaria, France, India, New Zealand, Poland, Russia, Spain, and the United States) and asserts that nearly all of the Gardasil/HPV vaccine lots examined contained residual HPV DNA attached to aluminum adjuvant particles. The speaker mentions that in the specific investigation, sixteen samples of Gardasil-4 contained residual HPV DNA fragments bound to aluminum adjuvant particles, and that all samples tested via PCR showed the same DNA sequence as described in the 2012 paper. The speaker claims that in 2014, the vaccine program for cervical cancer halted in Japan, and that the subsequent attention brought this issue to light publicly. The discussion attributes the major role to a Japanese expert, Ishii Ken (Ishii-sensei), described as a leading figure in Japan’s vaccine adverse-event research. The speaker recounts that, in the years around 2012–2014, efforts involved international collaboration with HR/HSA, FDA, and others, although logistical obstacles caused delays. The speaker notes that in 2012, 16 vaccine packages were distributed in nine countries for examination and that contamination persisted in all samples. They credit Japan with acting as a global relay for disseminating information about DNA contamination and its potential health implications. Further, the speaker references a broader context: the later emergence of literature discussing how DNA contamination might relate to adverse neurological or systemic symptoms, and the evolution of guidelines on acceptable residual DNA in vaccines. The discussion mentions that WHO and FDA guidelines permit changing permissible DNA limits over time, with higher thresholds introduced for manufacturing and regulatory purposes, raising questions about what constitutes safety and what is permissible in drug development. The dialogue closes with Speaker 1 alluding to the seriousness of the issue, noting deaths in the context of messenger-type vaccines and subsequent debates about vaccine safety, while acknowledging that those opposed to this view are also active.

The Pfizer and Moderna vaccines contain fragments of DNA, which can integrate into the genomic DNA of cells and become a permanent part of the cell. This poses a potential risk of autoimmune attacks and future cancer. The DNA contamination occurred during the production process, where a plasmid vector was used to scale up the production of the RNA template. The regulatory threshold for DNA in vaccines is outdated and not suitable for this new type of vaccine. The speaker believes that DNA sequencing should be done on vaccinated individuals' stem cells to determine if this theoretical risk has occurred. Informed consent is necessary, and the lack of transparency regarding the DNA contamination is concerning.

This is not conspiracy theory. This has been published in the BMJ by Retzaf Levy, and they go through this process: one where they ran these vaccines in the trial and how they changed that when they decided to go and inject the rest of the world. This is traditionally a mortal sin in vaccine manufacturing or in any sort of biologic manufacturing. The process is the product. You change the process, you have to go through trials again. And the EMA even asked them to do that, although they failed to. They asked for another trial of 250 people once they changed the process and that data was never delivered. So this bait and switch is very important for you to understand why the trial data is of absolute zero consequence to what we're actually seeing in the field. Those numbers are a caricature of what they're actually doing with these injections. They know something. Pfizer very early on they had the data on this from their trial, they knew this was going to happen and they quickly went out and acquired cancer companies. They put $43,000,000,000 into the acquisition of C Gen and they put $2,260,000,000 to acquire Trillium Therapeutics. Trillium was focused on blood cancers that have a CD one forty seven marker on them. Okay? That is one of the markers that is known to be involved in COVID. So, they have a very interesting window on those malignancies and, they're buying up the cancer companies that are probably gonna play the biggest role in benefiting from the mess that they've created. So, in summary, the Pfizer vaccines on the market are not the same formulation as what was tested in the clinical trials. This is a big bait and switch and it's a fraud. So you can't believe anything they're saying about the vaccine efficiency, which we have seen even those numbers decay over time. This is probably why. They're not really what they trialed. They gave you something different. There is significant DNA contamination that's found. Like, 10 out of 11 studies have found this, and the ones that haven't found it have some financial conflicts. So, I think the consensus is out. 10 out of 10 out of 10 of the real studies, are finding this. Several are through peer review, which have not been easy to get through peer review. The peer review journals do not like these papers. They get beat around in peer review for months to years, but they're making their way out now. There is also significant DNA contamination now found in five peer reviewed studies that were not looking at this. They were looking at people's blood and tissue and it was accidentally in there. Other people had to go sleuth it out. We've got cancer on the rise and there's several papers that report cancer post vaccination. Like, right at the site of injection, they'll see neoplasms. Alright? There is there's something going on here. This can't be ignored saying it's a coincidence anymore. Now this is these are liability free and they're often mandated. Okay? This may be the largest carcinogenic hit ever to the human population. And we have these on childhood schedules. We're giving these to pregnant women. This has gone absolutely off the rails.

A lawsuit against Merck alleges mishandling of Gardasil safety tests. Internal emails reveal Merck knew the vaccine was contaminated with HPV DNA fragments, which can trigger harmful immune responses when bound to the vaccine's aluminum adjuvant. Pathologist Dr. Soo Han Lee discovered high levels of HPV DNA in vaccines in 2011. These DNA fragments can activate the immune system, potentially leading to autoimmune disorders like POTS, and in rare cases, death. Internal emails allegedly show Merck downplayed the risks and tried to convince regulators not to test for HPV DNA. Merck's chief medical officer admitted they never looked for HPV DNA in their vaccine, instead using flawed testing methods. The lawsuit raises questions about regulatory oversight and Dr. Lee is set to testify in February. The speaker advocates for transparency, thorough safety studies, and informed consent regarding vaccines.

Mr. Kevin McKernan, a former leader at the Human Genome Project, discussed DNA contamination in Pfizer and Moderna vaccines. He highlighted the risks of insertional mutagenesis and integration into the genome, contradicting regulators' claims of little consequence. The DNA, found in lipid nanoparticles, can enter cells and potentially contribute to cancer. McKernan emphasized the inadequacy of current monitoring methods and called for a review of regulatory practices. The presence of DNA in these vaccines challenges existing safety standards and raises concerns about long-term effects.

Many labs, including Medicinal Genomics, found DNA contamination in Pfizer and Moderna mRNA vaccines. Regulators like the FDA and EMA admitted to this, but downplayed its significance. The SP 40 sequences omitted by Pfizer are crucial. DNA contamination can cause insertional mutagenesis, as stated in Moderna's patents. Regulatory agencies were deceived and failed to properly address the issue. This poses a serious risk that cannot be ignored.

The speaker claims that this is not conspiracy theory and cites a BMJ publication by Retzaf Levy, which describes a process in vaccine development: vaccines were trialed under one formulation, but when the decision was made to deploy them globally, the process was changed and the product injected to the rest of the world. The speaker asserts that changing the process requires new trials, yet the EMA asked for an additional trial of 250 people after the process change, and that data was never delivered. This is described as a “bait and switch,” asserted as crucial for understanding why trial data is of zero consequence to what’s seen in the field, implying that real-world outcomes do not match trial data and that the numbers from trials are a caricature of field performance. The speaker claims Pfizer had early data indicating what would happen and acted on that by acquiring cancer companies: $43,000,000,000 into the acquisition of C Gen and $2,260,000,000 to acquire Trillium Therapeutics. Trillium is described as focused on blood cancers with the CD147 marker (CD Adaptor 147) on them, a marker claimed to be known to be involved in COVID. The implication is that Pfizer is building an investment portfolio in cancer companies that would benefit from the consequences the speaker alleges they caused. In summary, the vaccines on the market are said to be not the same formulation as what was tested in clinical trials, labeling this a “bait and switch” and a fraud, and asserting that vaccine effectiveness numbers are not reliable because the products differ from trial formulations and because those numbers decay over time. The speaker alleges significant DNA contamination, stating that 10 out of 11 studies have found this, with the remaining studies allegedly constrained by financial conflicts. The claim is that consensus among real studies supports DNA contamination, with several studies through peer review, which the speaker notes is difficult for those papers to pass through peer review. It is claimed that five peer-reviewed studies not originally examining contamination found DNA in blood and tissue upon sleuthing. The speaker asserts that cancer is on the rise and that several papers report cancer post-vaccination, including neoplasms at the site of injection. The claim is that this situation cannot be dismissed as coincidence and is described as “liability free” and often mandated. The speaker posits that this may be the largest carcinogenic hit to the human population, with vaccines on childhood schedules and given to pregnant women, stating that “this has gone absolutely off the rails.”

The speaker discusses the issue of DNA contamination in mRNA COVID-19 vaccines and questions the FDA's handling of the situation. They explain that normally rigorous tests are required to ensure safety, but in this case, the FDA ignored those tests. The speaker also mentions that Moderna's own patent acknowledges concerns about DNA and insertional immunogenesis. They reveal that DNA fragments, including an antibiotic resistance gene and sequences from simian virus 40, were found in the vaccines. The speaker expresses shock at the FDA's lack of transparency and highlights the potential risks associated with DNA damage, such as cancer and birth defects.

The speaker claims sequences found in vaccines are now also being found in people. According to the speaker, five peer-reviewed studies involving RNA sequencing of vaccinated and unvaccinated individuals show DNA from vaccine manufacturers in patients' blood. The speaker cites studies by Ryan et al., Chakrabarty, Rhine, and Odek as evidence of Moderna and Pfizer vaccine sequences in patients' blood, suggesting blood supplies are contaminated. The speaker mentions three additional papers (Lee, Navel, and Krauszik) that, while not explicitly looking for it, also confirm residual plasmid sequences in recipients. One study, which investigated a particular disease, revealed differential gene expression in the cGAS-STING and interferon pathways, indicating a potential DNA stimulatory response. The speaker suggests this RNA sequencing data reveals the nature of the contaminant, with gene expression changes indicating a cGAS-STING-like event potentially induced by the DNA.

The speaker discusses DNA contamination found in Pfizer and Moderna mRNA vaccines, highlighting regulatory agencies' failure to address the issue. They mention potential risks of DNA integration and cancer development, urging for a review of regulatory practices. Concerns are raised about DNA levels exceeding limits, potential cell integration, and long-term presence in the body. The speaker emphasizes the need for better monitoring tools and the unique nature of DNA contamination in these vaccines.

The speakers discuss how initial kidney cells from monkeys used to make vaccines inadvertently gave people simian virus 40, which can lead to rapid cancer. One speaker says that this is one of the cancer-causing issues with the shots, explaining that it's supposed to stay out of the nucleus but can get in. One speaker says the initial claim was that the shot would stay local, in the arm, and dissipate quickly, but "they know that's not true." The other speaker mentions pseudouridine, a replacement nucleotide that is hard to break down, and that there's no study showing that it can be cleared from the body. This could be why some people have high antibody levels years later.

In this video, the speakers discuss new information about the mRNA vaccines and the presence of DNA in them. Researchers have found that some mRNA vaccines contain DNA fragments, which can cause issues with gene expression and potentially increase the risk of cancer. The presence of DNA in the vaccines is a manufacturing problem, and it is unclear why it was included. The DNA can enter cells and interfere with important genes, leading to various health problems. The speakers emphasize the need to investigate the extent of DNA contamination in the vaccines and consider stopping their production until the issue is resolved.

The speaker raises concerns about the contamination of current vaccines with DNA and the unknown consequences of this contamination. They argue that efforts should be made to eliminate DNA contamination, even if it increases production costs. The speaker mentions a researcher from MIT who accidentally discovered that mRNA vaccines were contaminated with DNA. They criticize Pfizer for testing vaccines from one process and then vaccinating billions of people with vaccines from another process, which were contaminated with DNA. The presence of DNA in the vaccines raises risks, including potential cancer development. The speaker believes it is misleading to claim that the vaccines have undergone clinical trials when they have not been properly studied. They call for more rigorous research before commercializing vaccines.

Speaker 0: They argue that because the vaccine is classified as such, they don’t have to worry about being sued. They claim immunity from liability is dependent on there being no fraud, and there clearly was fraud. Speaker 1: They say there is fraud. They note that immunity from liability depends on fraud, and in light of that, it matters. They explain that there was fraud. Speaker 0: Expresses surprise and asks for caveats about fraud. Acknowledges there were caveats. Speaker 1: Confirms there is fraud and says it makes the situation more interesting. Speaker 0: Asks how fraud is defined, noting that drugs were sold with multiple studies and only one was good. Speaker 1: Responds with a point about safety testing for the mRNA vaccines. States that the insufficient safety testing was done before release, and that the product injected into billions of people involved DNA plasmids. There is massive contamination in the shots actually delivered, including the SV40 promoter from simian virus 40. The point is that safety testing for one drug was completed, but people were injected with something different that had other components that were not tested, which is described as fraudulent. Speaker 0: Requests an explanation of the SV40 issue for the audience. Speaker 1: Describes production techniques used to generate the product. Explains that a plasmid, a circular piece of DNA, was used to produce the product in vats, with bacteria performing the production, later coated in lipid nanoparticle. There is a requirement to purify DNA and set standards for DNA contamination, with limits that cannot be exceeded. In this case, the problem isn’t only poor quality control but that there was a more painstaking way to produce the same product that did not involve DNA plasmids at all. Consequently, leftover material in vials injected into people contained DNA contamination across the board. Kevin McKernan tested vials, finding DNA contamination in the samples. Speaker 1: Explains that the DNA left over includes the SV40 promoter, a genetic trigger from simian virus 40, which is known to be carcinogenic. Since this promoter is left in the vials from injections given to people, it challenges the claim that the mRNA shots could not integrate into the genome. While acknowledging that there are cellular processes such as reverse transcription, the speaker asserts that even the claim of “no DNA” is false because there is DNA in the vials, specifically DNA with the SV40 promoter, a genetic engineering tool with carcinogenic potential. The speaker concludes that this appears to be fraud: injecting a different product into the public on the basis of safety testing that was conducted with a product produced by a different process. Speaker 0: Reiterates the conclusion: you can’t inject a different product into the public on the basis of safety testing that was done with something produced by a different process.

The speakers discuss the vaccination landscape around human papillomavirus (HPV) vaccines, focusing on a controversial issue they claim has been known and disseminated since early on: contamination with DNA (DNA residuals) from Deinococcus or related genetic material in vaccines and the implications of aluminum adjuvants used in Gardasil/Gardasil 9. - They begin by asserting that HPV vaccines, including Gardasil/Sil, have been the subject of remarkable legal actions worldwide, including four major lawsuits in Japan. They note that historically, in Japan, many young women and girls stood as plaintiffs, and that the core problem they highlight is the DNA contamination issue (referred to as “ディー エ ヌ エー 混 入 汚 染 問 題”). - The claim is that from early on, the Japanese Ministry of Health, Labour and Welfare and others acknowledged this contamination as central. They reference a 2012 paper that reportedly made the DNA contamination problem very clear, naming pathogens such as Human Papillomavirus, HPV, and DEIN? They describe that vaccine particles (HBV? HPBL DNA fragments) were found to be directly bound to aluminum adjuvant particles in Gardasil, implying a mechanism by which residual DNA could be involved in adverse effects. - The speakers say that the 2012 study, and subsequent work, led to attention from doctors worldwide who listened to the voices of women and girls and wondered what was happening with the vaccine recipients. They claim that samples showed that residual HPV DNA fragments were consistently present and directly linked to aluminum adjuvant particles, and that “PCR” detection indicated the same DNA sequences across samples. They mention that the 2012 paper’s findings were followed by reporting that, by 2014, vaccination had been suspended in Japan earlier than many would have expected. - They recount a process in which major scientists from various countries (France, the UK, and others) were involved in investigating adenoviral or genetic components (they reference Shihan? and others) and that the Japan-based researchers, including Ishii Ken, were central figures. They describe meetings, PowerPoint presentations at a hotel, and a sequence of visits to the UK and the US (including HR-related planning with U.S. FDA and the UK authorities) that were interrupted by closures in the Obama era, leading to documentation and discussions about the safety concerns. - The speakers claim that by the 2012 report and again by 2014, all vaccine samples from multiple countries contained residual DNA, and that Japan became a hub for disseminating awareness of these issues globally. They state that the issue was present not only in the early Gardasil (Gardasil-4) but also in later forms, with references to Gardasil-9 and the idea that the DNA contamination and adjuvant interactions could contribute to immune and neurological symptoms in recipients, particularly in women and girls. - They discuss changes to WHO and FDA guidelines on residual DNA limits, noting a progression from 10 picograms to higher thresholds over time, implying corporate interests in allowing higher residual DNA quantities in vaccines. They emphasize that the shift in limits is tied to pharmaceutical companies’ needs, not human biology changes, and argue that Japan highlighted the problem of Deinance-DNA contamination during the cervical cancer vaccine era, signaling that researchers, journalists, and victims were aware long before others. - Finally, Speaker 1 adds that two points became clear a year earlier: the disruption of messenger RNA–type vaccines as a response to safety concerns, and the subsequent rise in adverse outcomes after widespread vaccination, including deaths, which they claim intensified opposition to these vaccines. Note: The summary presents the speakers' claims and sequencing of events as described in the transcript without evaluation or endorsement.

The speaker raises concerns about the contamination of current vaccines with DNA and the unknown consequences of this contamination. They argue that efforts should be made to eliminate DNA contamination, even if it means higher production costs. The speaker mentions a researcher from MIT who discovered that mRNA vaccines were contaminated with DNA, despite DNA not being listed as a component. They criticize the authorities for testing vaccines without DNA contamination on a small group of people, but then vaccinating billions of people with contaminated vaccines. The speaker highlights the potential risks of DNA contamination, including the possibility of cancer. They conclude by stating that vaccines from the second process should undergo more rigorous studies before being commercialized.

The speaker discusses the issue of DNA contamination in mRNA COVID-19 vaccines and questions the FDA's handling of the situation. They explain that normally rigorous tests are required for genotoxicity and immunogenesis, but the FDA seemed to ignore these requirements. The speaker also mentions that Moderna's own patent acknowledges the concerns related to DNA and insertional immunogenesis. They reveal that DNA fragments, including an antibiotic resistance gene and sequences from simian virus 40, were found in the vaccines. The speaker expresses concern about the potential risks associated with DNA damage, such as cancer and birth defects. They criticize the FDA for downplaying the issue and emphasize the importance of transparency.

There is significant DNA contamination found in vaccines, with evidence from multiple researchers in Germany, Japan, and the U.S. Regulatory bodies like the FDA and EMA acknowledge this contamination but downplay its significance, relying on Pfizer's assurances. The clinical trials used cleaner DNA, but the mass-produced vaccines did not undergo the same purification, leading to increased background DNA and endotoxin levels. Regulators received a plasmid map missing crucial annotations, suggesting manipulation. Claims about expired vials and PCR methods used to measure contamination have been challenged, with evidence showing that Moderna's vaccines are cleaner. Regulators are allowing different measurement standards for RNA and DNA, raising concerns about transparency and integrity in the regulatory process.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

Kevin discovered that the vials used for vaccines are contaminated with bacterial DNA. This is concerning because the modified RNA used in these vaccines creates unusual genetic structures that don't occur naturally. Normally, DNA is in a double helix form, but with modified RNA, there are three strands attached to the DNA. The enzyme used to remove DNA, called DNase, cannot digest these triple-stranded genetic constructs, resulting in DNA contamination in the shots. Pfizer and Moderna should have addressed this issue during the manufacturing process by using different enzymes. This shows that assumptions cannot be made when working with new, unnatural products. The DNA used to manufacture the modified RNA was not properly removed, leading to multiple scary aspects of contamination.

The Pfizer vaccine is contaminated with plasma DNA, not just mRNA. This DNA is the DNA vector used as the template for the in vitro transcription reaction. This was discovered by sequencing vials of Pfizer vaccine from Colombia. It's surprising that there's any DNA in there. The speaker is alarmed about the possible consequences of this, including rare but serious side effects like death from cardiac arrest. Mixing DNA with a lipid complex allows it to enter cells and become a permanent fixture. This is a real hazard for genome modification of long-lived somatic cells, like stem cells, and could cause a sustained autoimmune attack. There is also a very real theoretical risk of future cancer in some people. The risk is not zero and it may be high enough that we ought to figure out if this is happening or not.

The speaker reports that they tested many vials and found DNA in all of them, with “a lot of DNA” in all vials and levels over the alleged EMA limits. They state these EMA limits are “too high” because they rely on “naked” DNA assessments rather than slip and nanoparticle encapsulated DNA assessment. They say the reason for highlighting these findings is the identification of a DNA fragment called the SV40 promoter enhancer, described as a strong mammalian promoter. They add that the presence of SV40 and the other DNA fragments can induce problems “that basically all lead to cancer,” and they summarize this as a connection between foreign DNA fragments and cancer-related outcomes. The speaker then shifts to gene mutations and describes investigating whether there are reports of specific gene mutations in the relevant context. They say they did not find the expected evidence—“I didn’t find nothing”—and clarify that they are not claiming a causal link. They describe their goal as generating hypotheses based on evidence. They state that the presence of SV40 in particular can cause genomic instability, including insertions and gene defects. They connect this to the idea of inserting cells containing billions of fragments of foreign DNA, which they say raises the potential for epigenetic modifications. They mention that Kevin discussed epigenetic methylation patterns in a preprint and that those methylation patterns are described there. They conclude that there are “questions that everybody kind of needs to answer,” which they say they asked in a Substack and invite readers to read it, referring to the Substack as containing the questions they want addressed.

The speaker raises concerns about the WHO's failures and the contamination of mRNA vaccines with DNA. They mention a research team in the US finding high levels of DNA contamination in the vaccine. German investigations also found significant exceedances of the allowable DNA limit. The speaker highlights the distribution of the vaccine throughout the body, including the ovaries, and appeals to the chairwoman to address the issue for vaccinated women of childbearing age. They mention having evidence to share but were prohibited from doing so. The speaker directs interested individuals to their website for more information.

The speaker discusses claims about modified RNA (MOD RNA) vaccines and DNA contamination in plasmids. They state that after creating MOD RNA on plasmids, the plasmid DNA remained and much of it could not be destroyed. They reference Kevin MacKurn’s discovery three years ago that vials were full of plasmid DNA, the whole plasmid and parts of it, and note that authorities allegedly minimized the issue, arguing that it doesn’t matter and that vaccines have saved millions of lives. The speaker asserts that the DNA in the vaccine vials was packaged in lipid nanoparticles and that this DNA would enter human cells. They reference colleagues’ publication last year (the INMODEO publication) showing that the DNA in the vaccine vials entered cells in culture and remained stable in cells for days, just as the MOD RNA did. Despite this, they say authorities dismissed the concerns with reassurance that nothing would happen. A pivotal point is attributed to a recent discovery by Kevin MacKinnon, claimed to be three weeks old, about what happens during transcription in the chromosome. The speaker explains that during production, byproducts occur and some mRNA strands do not detach from the DNA where they are formed, resulting in hybrids of DNA and RNA that come off together. The hybrids are described as dangerous, akin to “sparks of a sparkler,” and the speaker emphasizes that RNase H is an enzyme in the cell that takes care of these sparks and extinguishes them immediately. The speaker states that normal physicians don’t know about this, and they had to read up on RNase H after Jessica urged them to. The claimed consequence of failing to extinguish these hybrids is damage to the chromosome, with the metaphor that fires could light up and damage where they occur. The speaker asserts this could lead to “any illness that you see in the textbooks of medicine,” including tumors, neoplastic disease, autoimmune disease, developmental impairment, and death. They warn that the book of life—the genes and chromosomes—could be set on fire if these hybrids are not neutralized. The speaker says they have given interviews weekly, including one with Gary Null, and allege that this information is spreading worldwide. They claim that this situation is akin to attempted murder and exhort physicians globally not to participate, promising that those who do will be charged. They claim this issue is not limited to COVID vaccines but applies to all MOD RNA vaccines, including a flu MOD RNA vaccine now in use, and possibly veterinary vaccines, which they claim will be heavily contaminated with deadly dangerous hybrids. They urge authorities and controlling bodies to act, warning that they will face court if they fail to address the issue.